Excited to share our new work comparing the impact of long-term CFTR modulator therapy on
#CF lung pathogens & respiratory microbiome within a large, multi-centre & multi-national cohort of adults living with
#cysticfibrosis
www.medrxiv.org/content/10.1...
Remodelling of cystic fibrosis respiratory microbiota in response to extended Elexacaftor/Tezacaftor/Ivacaftor therapy
Background: Cystic fibrosis (CF) has profoundly changed since the introduction of CF Transmembrane Conductance Regulator modulator therapies (CFTRmt), a class of medications that improve function of t...
